Lyseng-Williamson KA (2019) Glucagon-like peptide-1 receptor analogues in type 2 diabetes: their use and differential features
As a game-changing new class of injectable diabetes and obesity drugs surges in popularity, widespread shortages and steep prices for brand-name GLP-1 drugs which also include Mounjaro and Zepbound have persisted, pushing droves of weight-loss hopefuls into a booming, less regulated secondary market for copies that are more affordable and readily available online
Oral semaglutide, therefore, represents an effective treatment option, that may lead to earlier initiation of GLP-1RA therapy in the diabetes treatment landscape
The risk is greater when semaglutide is used with insulin or an insulin secretagogue such as a sulfonylurea
They typically peak within the first few days after dose increases, then gradually improve as your body adapts
Direct answer: It may feel less strong, but it continues to support appetite control